Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03052101 · ClinicalTrials.gov registry record
Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 94
- Enrollment target
NCT03052101 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 94 participants.
The verdict
NCT03052101 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 94 participants
- Enrollment target
Study Summary
The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with pulmonary Langerhans cell histiocytosis (PLCH). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the Histiocytosis Association website. Patients will have access to the questionnaire via REDCap (an online data management system) and each patient will be provided with a link to complete the survey. The investigators plan on enrolling approximately 200 patients with PLCH for the purpose of this study. Secondary aims of this study include further characterization of the clinical aspects of disease and to establish a contact registry for these patients, in order to facilitate future studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2016-06 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03052101
The ClinicalTrials.gov registry entry for NCT03052101 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03052101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03052101 about?
NCT03052101 is a clinical study titled "Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis". The aim of this study is to conduct survey-based assessments for the safety of air travel in patients with pulmonary Langerhans cell histiocytosis (PLCH). The study will enroll patients through the clinic network at Rare Lung Disease Consortium (RLDC) and through the Histiocytosis Association websit...
What is the current status of trial NCT03052101?
This trial is currently completed. The enrollment target is 94 participants. The study started on 2016-06. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT03052101?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.